- What is Corundum Neuroscience's primary investment focus?
- Corundum Neuroscience focuses on advancing transformative neuroscience solutions, operating as a venture builder and fund.
- Which investment stages does Corundum Neuroscience typically participate in?
- Corundum Neuroscience participates in a wide range of investment stages, including Seed, A Round, B Round, C Round, D Round, E Round, F Round, and G Round.
- Can you name some of Corundum Neuroscience's notable portfolio companies?
- Corundum Neuroscience's portfolio includes companies such as GrayMatters Health, which develops digital therapy for mental health, and Lumen, a virtual nutritionist and metabolism measurement device.
- What is Corundum Neuroscience's geographic focus for investments?
- Corundum Neuroscience is based in Herzliya, Israel, and its parent company, Corundum Innovation, is a Japanese-based investment firm. The data does not specify preferred geographies beyond this.
- What is the typical investment range for Corundum Neuroscience?
- Corundum Neuroscience's investment range is between $720K and $20M.
- Has Corundum Neuroscience had any notable exits?
- Yes, WISDO HEALTH, a social health platform, was acquired by Talkspace in October 2025.
- What is the sector concentration of Corundum Neuroscience's portfolio?
- The majority of Corundum Neuroscience's portfolio companies, 10 out of 11, are in the Health Tech & Life Sciences sector. One company is in Media & Entertainment Technologies.
- When was Corundum Neuroscience founded?
- Corundum Neuroscience was founded in 2016.
